hif stabilizer trials in ckd/hd patients – what do the data really show?
Published 2 years ago • 3.1K plays • Length 25:08Download video MP4
Download video MP3
Similar videos
-
8:41
what does a regulator need to see before approving a hif stabilizer? pmda's perspective
-
5:50
hif stabilizers for anemia in ckd: phase 3 trials
-
58:57
isn-kdigo webinar on novel anemia therapies
-
6:32
hif stabilizers: management of anemia in ckd
-
4:10
anemia in ckd: hif stabilizers in clinical trials
-
8:23
future treatment of anemia in ckd: impact of hif stabilizers
-
6:12
payer perspective of hif stabilizers for anemia in ckd
-
41:11
addressing the disease burden associated with anemia of chronic kidney disease
-
26:49
what do health-system pharmacists need to know about hif-ph inhibitors in ckd-associated anemia?
-
45:43
hif-phis for anemia management in chronic kidney disease - dr. santosh varghese
-
3:53
anemia from chronic kidney disease (ckd)
-
27:47
addressing unmet needs in managing anemia in chronic kidney disease
-
52:14
future of anemia management in kidney disease - bc renal province-wide rounds (dec 2019)
-
3:54
future management of anemia in ckd
-
1:01:37
hif-phis for the treatment of anemia in ckd: ready or not?
-
59:09
the burden of anaemia in ckd patients and the unmet needs
-
34:24
challenges in anemia in ckd
-
6:51
role of anemia in ckd
-
8:49
payer perspective of anemia in ckd